These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16830064)

  • 1. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer.
    Stejskal D; Fiala RR
    Neoplasma; 2006; 53(4):343-6. PubMed ID: 16830064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
    Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
    Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
    Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
    Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
    Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
    Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer.
    Senga Y; Kimura G; Hattori T; Yoshida K
    Urology; 1996 Nov; 48(5):703-10. PubMed ID: 8911513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
    Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
    Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
    Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
    Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
    Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NMP-22 test. Is it useful in the follow-up of patients with superficial bladder tumor?].
    Pérez García FJ; Eyo A; Escaf Barmadah S; Fernández Gómez JM
    Arch Esp Urol; 2002 Dec; 55(10):1201-8. PubMed ID: 12611217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
    Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
    J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder.
    Watson JA; Burling K; Fitzpatrick P; Kay E; Kelly J; Fitzpatrick JM; Dervan PA; McCann A
    BJU Int; 2009 Mar; 103(5):694-7. PubMed ID: 19040529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of detection of specific nuclear protein of matrix 22 in the urine in diagnosis of urinary bladder cancer].
    Darenkov SP; Perlin DV; Chernyshev IV; Parshina VN; Ivanov AV; Iarovoĭ SK
    Urologiia; 2006; (6):48, 49-51. PubMed ID: 17315713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An office-based immunodiagnostic assay for detecting urinary nuclear matrix protein 52 in patients with bladder cancer.
    Attallah AM; Sakr HA; Ismail H; Abdel-Hady el-SK; El-Dosoky I
    BJU Int; 2005 Aug; 96(3):334-9. PubMed ID: 16042726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?
    Kiliç S; Bayraktar N; Beytur A; Ergin H; Bayraktar M; Egri M
    Int J Urol; 2006 Aug; 13(8):1079-85. PubMed ID: 16903933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.